StageZero Life Sciences Ltd. (SZLS.TO) TSX
0.04
+0(+0.00%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.4M |
| Enterprise Value | 6.19M |
| P/E Ratio | -0.04 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.17 |
| Price/Book Ratio | -0.07 |
| Enterprise/Revenue | 0.64 |
| Enterprise/EBITDA | -0.24 |
Fiscal Year
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | -3.01 |
| Operating Margin | -2.04 |
Management Effectiveness
| Return On Assets | -16.29 |
| Return On Equity | 4.82 |
Income Statement
| Revenue | 3.8M |
| Revenue/Share | 0.04 |
| Gross Profit | -403,745 |
| EBITDA | -10.76M |
| Net Income | -11.42M |
| Diluted EPS | -0.11 |
Balance Sheet
| Total Cash | 15,032 |
| Total Cash/Share | 0 |
| Total Debt | 2.13M |
| Total Debt/Equity | -0.24 |
| Current Ratio | 0.04 |
| Book Value Per Share | -0.08 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 0.06 |
| 52-Week Low | 0.04 |
| Moving Average 50 Days | 0.04 |
| Moving Average 200 Days | 0.04 |
Statistics
| Average Volume | 215,684 |
| Shares Outstanding | 123.55M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | September 18, 2020 |
